These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 26186733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L, d'Aure D, Bérard E, Rouquette I, Delisle MB, Courtade-Saïdi M.
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [Abstract] [Full Text] [Related]

  • 4. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma.
    Das DK, Al-Waheeb SK, George SS, Haji BI, Mallik MK.
    Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB, Şenol S, Şimşek BÇ, Sağıroğlu J, Aydın A.
    Int J Clin Exp Pathol; 2015 Jun; 8(4):3670-80. PubMed ID: 26097548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
    Addati T, Achille G, Centrone M, Petroni S, Popescu O, Russo S, Grammatica L, Simone G.
    Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M, Granitto A, Martini M, Capodimonti S, Cocomazzi A, Musarra T, Fiorentino V, Pontecorvi A, Lombardi CP, Fadda G, Pantanowitz L, Larocca LM, Rossi ED.
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.
    Ozolins A, Narbuts Z, Strumfa I, Volanska G, Stepanovs K, Gardovskis J.
    Medicina (Kaunas); 2012 Mar; 48(10):507-14. PubMed ID: 23324246
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms.
    Rossi ED, Bizzarro T, Martini M, Capodimonti S, Sarti D, Cenci T, Bilotta M, Fadda G, Larocca LM.
    Endocrine; 2016 Dec; 54(3):723-732. PubMed ID: 26818914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL, Wang J, Zhang FJ, Zhao N, Gao BL.
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control.
    Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R.
    Thyroid; 2011 Oct; 21(10):1067-73. PubMed ID: 21875347
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the follicular patterned thyroid lesions based on the WHO 2022 criteria with an emphasis on the grey-zone lesions.
    Misra S, Dhawan S, Badwal S, Sengupta A, Khosla A, Agarwal SK, Rao S.
    Ann Diagn Pathol; 2024 Aug; 71():152282. PubMed ID: 38522359
    [Abstract] [Full Text] [Related]

  • 20. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G, Wang J, Zhou Z, Li T, Tang F.
    J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.